EVH · XBRL financial data

Evolent Health financial statements, every quarter

The same tables from 12 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

How these numbers work

Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
* marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
0 means a filing states zero; a dash (—) means no filing states that number.
“year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
Shares outstanding come from each filing's cover page, as of the date printed there.
Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

Fiscal quarters (EVH's year ends in late December)

In millions of dollars	Q3 FY23Sep 30, 2023	Q4 FY23Dec 31, 2023	Q1 FY24Mar 31, 2024	Q2 FY24Jun 30, 2024	Q3 FY24Sep 30, 2024	Q4 FY24Dec 31, 2024	Q1 FY25Mar 31, 2025	Q2 FY25Jun 30, 2025	Q3 FY25Sep 30, 2025	Q4 FY25Dec 31, 2025	Q1 FY26Mar 31, 2026	Q2 FY26Jun 30, 2026
Revenue	511	556	—	—	—	—	—	—	—	—	—	—
Revenue from contracts with customers	511	556	640	647	621	647	484	444	480	469	496	653
Cost of revenue	387	454*	536	540	541	571*	381	344	380	371*	412	572
Selling, general and administrative	97	81*	79	69	67	48*	78	75	78	73*	73	69
Total operating expenses	529	577	—	—	—	—	—	—	—	—	—	—
Operating income (loss)	(18)	(21)*	(13)	8	(16)	(19)*	(2)	(1)	1	(408)*	(11)	(10)
Interest income	1	3*	3	1	1	1*	1	1	1	1*	1	1
Interest expense	15	12*	6	6	6	7*	10	12	16	19*	17	17
Other income (expense)	(0)	(0)*	0	(0)	(0)	0*	(0)	(0)	0	0*	1	0
Income tax expense (benefit)	(6)	(15)*	1	(0)	(1)	(1)*	1	(1)	1	(2)*	1	3
Net income (loss)	(25)	(33)	(17)	2	(23)	(23)	(65)	(20)	(21)	(429)	(27)	(28)
Earnings per share, basic USD per share	(0.30)	(0.36)	(0.22)	(0.06)	(0.27)	(0.27)	(0.63)	(0.44)	(0.24)	(3.84)	(0.24)	(0.25)
Earnings per share, diluted USD per share	(0.30)	(0.36)	(0.22)	(0.06)	(0.27)	(0.27)	(0.63)	(0.44)	(0.24)	(3.84)	(0.24)	(0.25)
Weighted average shares, basic millions of shares	112	114*	114	115	115	115*	115	116	114	112*	112	113
Weighted average shares, diluted millions of shares	112	114*	114	115	115	115*	115	116	114	112*	112	113

Fiscal quarters (EVH's year ends in late December)

In millions of dollars	Q3 FY23Sep 30, 2023	Q4 FY23Dec 31, 2023	Q1 FY24Mar 31, 2024	Q2 FY24Jun 30, 2024	Q3 FY24Sep 30, 2024	Q4 FY24Dec 31, 2024	Q1 FY25Mar 31, 2025	Q2 FY25Jun 30, 2025	Q3 FY25Sep 30, 2025	Q4 FY25Dec 31, 2025	Q1 FY26Mar 31, 2026	Q2 FY26Jun 30, 2026
Cash and cash equivalents	185	193	165	101	97	104	247	151	117	152	142	116
Accounts receivable	394	447	428	374	408	415	430	359	387	310	314	449
Prepaid and other current assets	37	30	25	26	23	29	35	28	22	19	22	23
Total current assets	639	684	669	521	544	607	728	562	570	506	502	611
Property and equipment, net	80	78	76	75	74	73	74	77	80	81	81	82
Right-of-use asset	17	12	11	10	9	6	6	5	5	4	4	3
Goodwill	1,118	1,117	1,117	1,117	1,137	1,137	1,137	1,137	1,075	694	694	694
Total assets	2,670	2,680	2,644	2,475	2,502	2,544	2,653	2,462	2,453	1,899	1,879	1,972
Accounts payable	52	48	77	39	50	96	58	69	72	60	63	39
Accrued liabilities	194	150	165	85	120	66	100	64	61	66	45	44
Total current liabilities	615	674	659	483	524	716	739	558	430	385	381	493
Long-term debt	600	597	598	599	600	491	648	648	1,055	971	973	966
Lease liability, non-current	40	38	32	31	29	25	16	8	4	4	3	2
Total liabilities	1,398	1,434	1,414	1,237	1,276	1,353	1,525	1,337	1,611	1,484	1,482	1,589
Accumulated deficit	(686)	(719)	(736)	(735)	(758)	(781)	(845)	(865)	(886)	(1,315)	(1,342)	(1,370)
Total stockholders' equity	1,096	1,068	1,048	1,054	1,039	1,001	936	896	842	415	396	383
Total liabilities and equity	2,670	2,680	2,644	2,475	2,502	2,544	2,653	2,462	2,453	1,899	1,879	1,972
Common shares outstanding (cover page) millions of shares	115	115	116	116	117	117	117	118	112	112	112	113

Fiscal quarters (EVH's year ends in late December)

In millions of dollars	Q3 FY23Sep 30, 2023	Q4 FY23Dec 31, 2023	Q1 FY24Mar 31, 2024	Q2 FY24Jun 30, 2024	Q3 FY24Sep 30, 2024	Q4 FY24Dec 31, 2024	Q1 FY25Mar 31, 2025	Q2 FY25Jun 30, 2025	Q3 FY25Sep 30, 2025	Q4 FY25Dec 31, 2025	Q1 FY26Mar 31, 2026	Q2 FY26Jun 30, 2026
Net income (loss)	(25)	(33)	(17)	2	(23)	(23)	(65)	(20)	(21)	(429)	(27)	(28)
Stock-based compensation	10*	11*	19	13*	14*	(6)*	11	12*	15*	2*	11	15*
Depreciation and amortization	32*	30*	30	30*	30*	29*	24	23*	24*	45*	22	22*
Net cash from operating activities	61*	89*	5	21*	19*	(26)*	5	(30)*	16*	49*	(1)	(9)*
Net cash from investing activities	(6)*	(6)*	(10)	(14)*	(20)*	(20)*	(13)	(61)*	(9)*	82*	(6)	(7)*
Share repurchases	—	year only	—	—	—	0*	—	—	—	0*	—	—
Proceeds from long-term debt	0*	391*	—	—	—	—	—	—	—	—	—	—
Repayments of long-term debt	10*	417*	0	0*	0*	0*	63	0*	167*	—	—	—
Net cash from financing activities	(37)*	(84)*	15	(103)*	(9)*	97*	108	(9)*	(42)*	(93)*	(4)	(11)*
Net change in cash	17*	(1)*	10	(96)*	(10)*	51*	99	(100)*	(35)*	38*	(12)	(27)*

SIC 8741 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen

SIC 8741 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
Runway shows only for companies burning cash with under $10B of public float.
* marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.

Company	Cash ($M)	Revenue, quarter ($M)	Operating cash flow, quarter ($M)	Shares outstanding	Runway	Quarter
Evolent Health	116	653	(9.3)*	113.1M	12.4 quarters	Q2 FY26 10-QJun 30, 2026
Astrana Health	401	973	33*	55.7M	—	Q2 FY26 10-QJun 30, 2026
ICF International	4.6	474	100*	17.9M	—	Q2 FY26 10-QJun 30, 2026
Premier	43	240	16	82.7M	—	Q1 FY26 10-QSep 30, 2025
Onterris	13	187	6.2*	35.1M	—	Q2 FY26 10-QJun 30, 2026
Huron Consulting Group	26	491	57*	15.8M	—	Q3 FY26 10-QSep 30, 2026
V2X	265	1,271	67*	31.4M	—	Q3 FY26 10-QOct 2, 2026
TSS	68	35	7.6*	28.2M	—	Q2 FY26 10-Q/AJun 30, 2026
Exponent	67	172	31*	47.5M	—	Q2 FY26 10-QJul 3, 2026

Not investment advice. Not affiliated with the U.S. SEC.